FN London

Financial News

News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

News

Banks are among the biggest risers on UK’s green light for Oxford-AstraZeneca vaccine

Lenders bounce back after post-Christmas fall as new inoculation is approved

By

Penny Sukhraj

The lift in banking stocks comes a day after bank stocks fell in the first post-Christmas trading, which analysts attributed to a lack of clarity of how markets would operate come 1 January, as the transition period for Brexit ends on 31 December
The lift in banking stocks comes a day after bank stocks fell in the first post-Christmas trading, which analysts attributed to a lack of clarity of how markets would operate come 1 January, as the transition period for Brexit ends on 31 December Photo: Barry Lewis/Getty Images

Banking stocks were among the top climbers on the FTSE 100, which rose on 30 December on the back of the UK government’s approval of the Oxford-AstraZeneca coronavirus vaccine.

Pricing in the news of the vaccine saw an uptick across the banks including NatWest (+2.75%), Lloyds Banking Group (+2.24%), Standard Chartered (+2.03%), HSBC (+1.64%) and Barclays (+1.47%), along with financial services firms like Legal & General (1.81%).

WSJ Logo
How Trump Got His ‘Big, Beautiful Bill’ Across the Finish LineExternal link

How Trump Got His ‘Big, Beautiful Bill’ Across the Finish Line

Wall Street Worries as Crisis-Level Deficits Become the Government’s Default Mode

French Regulators Fine Shein for Misleading Discounts

JPMorgan Is Revamping Its Bank for the Superrich to Cater to Global Clientele

U.K. Government Bonds, Pound Recover After Prime Minister Backs Treasury Chief